A new key in breast cancer metastasis

Slides:



Advertisements
Similar presentations
Integrin-EGFR Cross-Activation Elizabeth Brooks Department of Chemical Engineering University of Massachusetts, Amherst Peyton Lab Group Meeting December.
Advertisements

P53 mutations in triple negative breast cancer upregulate endosomal recycling of epidermal growth factor receptor (EGFR) increasing its oncogenic potency 
Thymocyte development summary
Volume 76, Issue 9, Pages (November 2009)
T-ALL: Home Is where the CXCL12 Is
Volume 7, Issue 3, Pages (March 2005)
David Largaespada, Nancy Ratner  Cancer Cell 
Destruction of RhoA CULtivates Actin
The Cbl Family and Other Ubiquitin Ligases
HER2/HER3 heterodimers in prostate cancer
Laetitia Seguin, Sara M. Weis, David A. Cheresh  Cell Stem Cell 
Volume 29, Issue 5, Pages (November 2008)
A Sweet New Role for EGFR in Cancer
Agonizing Integrin Antagonists?
Cell tension, matrix mechanics, and cancer development
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
Biology and Clinical Applications of Pancreatic Cancer Stem Cells
Endocytosis Conducts the Cell Signaling Orchestra
Volume 5, Issue 5, Pages (November 2003)
Suppressing NFAT Increases VEGF Signaling in Hemangiomas
The Wind God Promotes Lung Cancer
Integrins and Mutant p53 on the Road to Metastasis
Integrins and Mutant p53 on the Road to Metastasis
Methed-Up FOXOs Can't In-Akt-ivate
Endocytic Trafficking of Integrins in Cell Migration
Identification of TOR Signaling Complexes
Coordinate Transcriptional Regulation by ERG and Androgen Receptor in Fusion- Positive Prostate Cancers  Yu Chen, Charles L. Sawyers  Cancer Cell  Volume.
Volume 142, Issue 4, Pages (August 2010)
Great Expectations for PIP: Phosphoinositides as Regulators of Signaling During Development and Disease  Lara C. Skwarek, Gabrielle L. Boulianne  Developmental.
PTEN Enters the Nuclear Age
Complementing T Cells’ Functions: Bringing in Metabolism Matters
Volume 22, Issue 6, Pages (December 2012)
TGF-² Signaling Pathway in Lung Adenocarcinoma Invasion
Shannon Otsuka, BSc, Gwyn Bebb, BMBCh, PhD, FRCPC 
Volume 76, Issue 9, Pages (November 2009)
Douglas R. Green, Beth Levine  Cell 
Cellular signalling: Stressing the importance of PIP3
Connecting Mitochondria and Innate Immunity
Shedding Light on Mammalian Microautophagy
Defective neutrophil rolling and transmigration in acute uremia
Chemokines and leukocyte trafficking in rheumatoid arthritis
14-3-3ζ Turns TGF-β to the Dark Side
Robert J. Lefkowitz, Keshava Rajagopal, Erin J. Whalen  Molecular Cell 
T Cells Are Smad’ly in Love with Galectin-9
LKB1 and Src: Antagonistic Regulators of Tumor Growth and Metastasis
Finding the Right Partner: Science or ART?
Powering Tumor Metastasis with Recycled Fuel
William G. Nelson, Michael C. Haffner, Srinivasan Yegnasubramanian 
Cell Migration: A Physically Integrated Molecular Process
Marco Terenzio, Giampietro Schiavo, Mike Fainzilber  Neuron 
Fibronectin at Select Sites Binds Multiple Growth Factors and Enhances their Activity: Expansion of the Collaborative ECM-GF Paradigm  Jia Zhu, Richard.
The Expanding Cosmos of Nuclear Receptor Coactivators
Volume 84, Issue 3, Pages (February 1996)
EMT and proteinuria as progression factors
Michael J. Clague, Han Liu, Sylvie Urbé  Developmental Cell 
Mesenchymal Stromal Cells: Sensors and Switchers of Inflammation
A Wnt Survival Guide: From Flies to Human Disease
Volume 76, Issue 5, Pages (September 2009)
The new kid on the block(ade) of the IGF-1 receptor
Volume 1, Issue 3, Pages (April 2002)
Mutant BRAF Melanomas—Dependence and Resistance
Friends with Benefits: Microenvironmental NRG1β and HGF Mediate HER2-Targeted Resistance in L-HER2+ and HER2E Breast Cancer  Sarah B. Crist, Cyrus M.
Crashing waves of destruction
The TRIP from ULF to ARF Cancer Cell
Gankyrin: An intriguing name for a novel regulator of p53 and RB
New Myc-anisms for DNA Replication and Tumorigenesis?
Successful targeting of ErbB2 receptors—is PTEN the key?
The Cbl Family and Other Ubiquitin Ligases
Skp2, the FoxO1 hunter Cancer Cell
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
Presentation transcript:

A new key in breast cancer metastasis Jeffrey L. Benovic, Adriano Marchese  Cancer Cell  Volume 6, Issue 5, Pages 429-430 (November 2004) DOI: 10.1016/j.ccr.2004.10.017

Figure 1 Role of HER2 and CXCR4 in cell migration, adhesion, and invasion CXCL12 (SDF-1α)-promoted chemotaxis through CXCR4 involves activation of the heterotrimeric G protein αi and may involve arrestins and activation of p38 MAP kinase (Sun et al., 2002). Activated CXCR4 also appears to enhance integrin-mediated adhesion, which may require RhoA, Cdc42, and actin (Soede et al., 2001). Taken together, these processes contribute to CXCR4-mediated migration, adhesion, and invasion. In order to ensure that signals are of the appropriate magnitude and duration, CXCR4 is also subject to a complex series of regulatory events. Upon ligand binding, CXCR4 is rapidly monoubiquitinated by the E3 ubiquitin ligase AIP4 (Marchese et al., 2003). The ubiquitin moiety (Ub) serves as a sorting signal to enter the multivesicular body (MVB) for subsequent degradation in lysosomes. Overexpression of HER2 leads to increased expression of CXCR4, which appears to occur via two independent mechanisms (Li et al., 2004). One is through a PI3K/Akt/mTOR-mediated pathway that leads to an increase in the rate of CXCR4 synthesis. HER2 overexpression also attenuates CXCR4 ubiquitination and degradation of the receptor, potentially enhancing recycling of CXCR4 to the cell surface. The increased surface expression of CXCR4 makes the cells more responsive to CXCL12 stimulation and can result in increased metastasis. Cancer Cell 2004 6, 429-430DOI: (10.1016/j.ccr.2004.10.017)